What is the purpose of this trial?
The study was conducted to assess the safety and tolerability of (1) polyethylene glycol (PEG) PEGylated Recombinant Human Hyaluronidase (PEGPH20) in combination with cisplatin (CIS) and gemcitabine (GEM) (PEGCISGEM), and (2) PEGPH20 in combination with CIS, GEM, and atezolizumab (PEGCISGEMATEZO).
Start Date: 03/02/2018
End Date: 07/03/2020
Last Updated: 03/07/2018
Study HIC#: 2000021415